Backstrom Jay T. sold AGIO
July 8, 2026 · Form 4 insider transaction
Backstrom Jay T. sold 1,447 shares of Agios Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,447
Price
$0.00
Total value
N/A
InsiderBackstrom Jay T.
RoleDirector
SecurityRestricted stock units
Transaction codeM: Option exercise
Transaction dateJuly 8, 2026
Filing dateJuly 10, 2026
Shares owned after2,894
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.; The restricted stock units were granted on July 8, 2025. Beginning on July 8, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.